What's Happening?
Adaptyx Biosciences has presented the first continuous, multi-day measurement of free cortisol in humans at the American Diabetes Association's Scientific Sessions. The data, obtained using a wearable sensor, demonstrated the ability to track cortisol levels
continuously, capturing physiological rhythms that traditional tests miss. This breakthrough offers a new way to monitor cortisol, a hormone impacting glucose control, cardiovascular health, and stress response. The technology uses DNA-based molecular switches to provide minute-level resolution of cortisol concentrations.
Why It's Important?
The ability to continuously monitor cortisol levels represents a significant advancement in understanding and managing conditions influenced by this hormone, such as diabetes, hypertension, and depression. Adaptyx's technology could transform clinical care by providing real-time insights into hormonal fluctuations, enabling more precise treatment strategies. This innovation has the potential to improve patient outcomes and reduce healthcare costs by addressing the root causes of various health issues rather than just their symptoms.
